Early-onset Alzheimer's Patients Accumulate Symptoms Years Before Diagnosis
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

For listenersOffer from Amazon

Turn quiet afternoons into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

A study of 407 people diagnosed with Alzheimer’s before age 65 found that several health conditions and health-care use were more common in the years before diagnosis, especially during the final five years. High blood pressure and high cholesterol were not more common than among matched controls; researchers say no individual symptom predicts the disease.

A study led by researchers at the University of Oulu and the University of Eastern Finland found that people diagnosed with Alzheimer’s before age 65 had a growing range of health problems and increased health-care use in the years before diagnosis. The results, based on records for 407 patients and more than 4,000 matched controls, also found that high blood pressure and high cholesterol were not more common among the early-onset patients.

The researchers examined health conditions recorded during the 15 years before diagnosis. They found no significant differences in illness burden between the patient and control groups 11 to 15 years before diagnosis. Differences became more apparent closer to diagnosis, particularly in the final five years.

Compared with controls matched for age and sex, people who later received an early-onset Alzheimer’s diagnosis were more likely to have records of depression, dizziness, headaches, traumatic brain injuries, epilepsy and cerebrovascular disorders. Thyroid diseases and problems related to heavy alcohol use were also more common. Tinnitus and hearing loss were more common six to 10 years before diagnosis.

Health-care use rose alongside the recorded conditions, with the steepest increase in visits during the final year before diagnosis. The study drew on memory-clinic patient data from Oulu University Hospital and Kuopio University Hospital, linked with nationwide health-register information. It was published in the journal Alzheimer’s & Dementia.

At a glance
reportWhen: Study published in 2026; report dated O…
The developmentA Finnish case-control study reports that health problems and health-care visits accumulate in the years before early-onset Alzheimer’s diagnosis, with differences emerging mainly closer to diagnosis.

A Wider Pattern Before Diagnosis

The findings describe health conditions and health-care visits recorded before early-onset Alzheimer’s diagnoses in working-age adults. The researchers say that the pattern may inform awareness of possible neurodegenerative disease, but the study does not establish that these conditions cause Alzheimer’s or can be used to diagnose it.

The conditions identified are not specific to Alzheimer’s, and the authors say no single disease or symptom predicts it. The results compare group-level health records before diagnosis; they do not provide a screening test or show that earlier recognition would change disease outcomes.

Amazon

memory foam hearing loss pillow

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

How Early-Onset Cases Differ

Early-onset Alzheimer’s refers here to disease diagnosed before age 65. Diagnosis in working-age people can be delayed by several years after symptoms begin, according to the report. The study focused on the period before diagnosis and compared patients with people of similar age and sex who did not have a neurodegenerative disease.

Cardiovascular risk factors, including high blood pressure and elevated blood lipids, are widely associated with Alzheimer’s risk, particularly in discussions of later-onset disease. In this study, however, those factors were not more common among people with early-onset Alzheimer’s than among controls. Lead investigator Johanna Krüger said the findings support the view that early-onset disease is not simply a younger-age version of late-onset Alzheimer’s. The study suggests possible differences in health profiles, but does not establish the biological mechanisms behind them.

““Our results suggest that, in the years before diagnosis, patients may accumulate a variety of seemingly unrelated symptoms and healthcare encounters.””

— Laura Leppänen, doctoral researcher at the University of Oulu and the study’s first author

Amazon

dizziness relief supplement

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Limits of the Health Record Findings

The study identifies associations in health records, not causes. It does not show whether the recorded conditions were early manifestations of Alzheimer’s, separate health problems, or a combination of factors. Nor does it establish that the pattern can reliably identify which individual will develop the disease.

The report does not provide evidence that any particular symptom or combination of visits is an effective screening method. The findings are based on patients connected to two Finnish memory clinics and linked national records; how well the pattern applies to other populations is not specified in the supplied study summary. The reasons cardiovascular risk factors were not more common in this group also remain unclear.

Amazon

headache relief essential oil

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Further Research and Earlier Recognition

The published study describes a record-based pattern for further investigation but does not set out a new diagnostic pathway. Further research would be needed to test whether the observed conditions and rising health-care use can help identify early-onset Alzheimer’s earlier, and whether findings from the Finnish cohort hold in other settings.

The authors emphasize the combined pattern, rather than treating any listed condition as a warning sign on its own. People with health concerns should discuss them with a qualified health professional; the study is not medical advice and cannot diagnose Alzheimer’s.

Amazon

depression management journal

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Key Questions

What did the study find before early-onset Alzheimer’s diagnosis?

It found that several health conditions and health-care use became more common among people later diagnosed before age 65, especially in the five years before diagnosis. The study did not find significant differences 11 to 15 years beforehand.

Which conditions were more common in the patient group?

Compared with matched controls, patients were more likely to have records of depression, dizziness, headaches, traumatic brain injuries, epilepsy, cerebrovascular disorders, thyroid diseases and problems related to heavy alcohol use. Tinnitus and hearing loss were more common six to 10 years before diagnosis.

Did the study find higher blood pressure or cholesterol among patients?

No. The researchers reported that high blood pressure and high cholesterol were not more common among early-onset Alzheimer’s patients than among the age- and sex-matched controls.

Can these symptoms predict Alzheimer’s in an individual?

No. The researchers said no single disease or symptom predicts Alzheimer’s. The study describes group-level patterns in health records and does not establish a diagnostic test.

Who took part in the study?

The analysis included 407 people with early-onset Alzheimer’s and more than 4,000 age- and sex-matched controls, using Finnish memory-clinic data linked to nationwide health registers.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
COLD & FLU SEASO

Cold & flu season Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

Cdc Parasite Outbreak

The CDC is investigating a parasite outbreak in North Carolina affecting dozens of residents. Details are still emerging about the source and scope.

F.D.A. Advisory Panel Endorses Controversial Cancer Blood Test

An F.D.A. advisory panel has recommended approval of a new blood test for cancer detection, sparking debate over its accuracy and clinical utility.

Sonoma Pharmaceuticals Surges In Global Coverage

Sonoma Pharmaceuticals experiences a significant surge in international coverage, with 14 mentions in recent media tracking data, highlighting increased global interest.

Keeping Your Energy Up with Easy Daily Habits

Discover simple daily habits that naturally boost your energy—no gimmicks, just practical tips to feel more alert and vibrant every day.